InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Zentalis Pharmaceuticals, Inc.

ZNTL Clue Score26
United States Fiscal year ends December CIK 0001725160 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Walters Group
14 Aug 2026
10% owner
Buy
4,335,000
$3.50
$15.17M
Vincent Vultaggio
10 Feb 2026
PAO and PFO
Sold on a plan
6,894
$2.42
$16.70K
Julia Marie Eastland
9 Feb 2026
CEO & President
Sell
889
$2.39
$2.13K
Vincent Vultaggio
9 Feb 2026
PAO and PFO
Sold on a plan
3,379
$2.39
$8.09K
Ingmar Bruns
9 Feb 2026
Chief Medical Officer
Sell
335
$2.39
$801.62
Julia Marie Eastland
6 Feb 2026
CEO & President
Sell
7,866
$2.43
$19.11K
Vincent Vultaggio
6 Feb 2026
PAO and PFO
Sold on a plan
29,951
$2.43
$72.77K
Ingmar Bruns
6 Feb 2026
Chief Medical Officer
Sell
2,962
$2.43
$7.20K
Vincent Vultaggio
3 Feb 2026
PAO and PFO
Sold on a plan
556
$2.52
$1.40K
Vincent Vultaggio
2 Feb 2026
PAO and PFO
Sold on a plan
2,540
$2.55
$6.48K
Walters Group
31 Dec 2025
10% owner
Buy
6,459,973
$1.20
$7.75M
Matrix Capital Management Company, LP
15 Dec 2025
10% owner
Sell indirect
7,500,000
$1.33
$9.98M

What was left out

Form 4 filings counted 18
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 0
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 409,427
History held since 8 Apr 2020